Covestor
ANIP icon

Covestor’s ANI Pharmaceuticals ANIP Stock Holding History

Covestor’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$10K Hold
142
– – 0.01% 1432
2026
Q2 		$11K Buy
142
+26
+22% +$2.09K 0.01% 1481
2026
Q1 		$9K Buy
116
+4
+4% +$312 0.01% 1442
2025
Q4 		$9K Buy
112
+1
+0.9% +$87 ﹤0.01% 1606
2025
Q3 		$10K Buy
111
+109
+5,450% +$8.89K 0.01% 1584
2025
Q2 		$0 Hold
2
– – ﹤0.01% 2170
2025
Q1 		$0 Sell
2
-45
-96% -$2.69K ﹤0.01% 2178
2024
Q4 		$3K Buy
47
+29
+161% +$1.66K ﹤0.01% 1781
2024
Q3 		$1K Buy
18
+6
+50% +$366 ﹤0.01% 1884
2024
Q2 		$1K Buy
12
+1
+9% +$65 ﹤0.01% 1917
2024
Q1 		$1K Buy
11
+9
+450% +$543 ﹤0.01% 1893
2023
Q4 		$0 Hold
2
– – ﹤0.01% 2108
2023
Q3 		$0 Buy
+2
New +$115 ﹤0.01% 2079

Other funds holding ANIP

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $229B AUM 33.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $234B AUM 43.58% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Covestor's ANIP Position: Q3 2026 in Review

Covestor held its ANI Pharmaceuticals (ANIP) position steady in Q3 2026 at 142 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1432.

Covestor first reported a position in ANIP in Q3 2023 and has held it in 13 quarters since. The position peaked at $11K in Q2 2026. 216 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Covestor held 142 shares of ANI Pharmaceuticals worth $10K as of Q3 2026.
  • Covestor left its ANI Pharmaceuticals share count unchanged in Q3 2026.
  • ANI Pharmaceuticals made up 0.01% of Covestor's portfolio in Q3 2026, its #1432 holding.
  • Covestor first reported a position in ANI Pharmaceuticals in Q3 2023 and has held it in 13 quarters since.
  • Covestor's ANI Pharmaceuticals position peaked at $11K in Q2 2026.
  • 216 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Covestor's 13F filing for Q3 2026, filed 30 Oct 2026.